Head of the Centre on Global Health Security at Chatham House, Professor of Infectious Disease Epidemiology at London School of Hygiene and Tropical Medicine, and Chairman of Public Health England, UK
Dr David L. Heymann is currently chair of the Health Protection Agency, United Kingdom, Head of the Centre on Global Health Security at Chatham House, London and Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine. Until April 2009 he was Assistant Director-General for Health Security Environment and Representative of the Director-General for Polio Eradication at the World Health Organization (WHO). Prior to that, from July 1998 until July 2003, he was Executive Director of the WHO Communicable Diseases Cluster which included WHO’s programmes on infectious and tropical diseases, and from which the public health response to SARS was mounted in 2003. From October 1995 to July 1998, he was Director of the WHO Programme on Emerging and other Communicable Diseases, and prior to that was the Chief of research activities in the WHO Global Programme on AIDS. Dr Heymann has worked in the area of public health for the past 35 years, 25 of which were on various assignments from the US Centers for Disease Control and Prevention (CDC), and 10 of which have been with the World Health Organization (WHO).
Before joining WHO, Dr Heymann worked for thirteen years as a medical epidemiologist in sub-Saharan Africa (Cameroon, Cote d’Ivoire, Malawi, and the Democratic Republic of Congo – formerly Zaire) on assignment from the US Centers for Disease Control and Prevention (CDC) in CDC-supported activities. Dr Heymann's educational qualifications include a B.A. from the Pennsylvania State University, an M.D. from Wake Forest University, a Diploma in Tropical Medicine and Hygiene from the London School of Hygiene and Tropical Medicine, and practical epidemiology training in the two year Epidemic Intelligence Service (EIS) of CDC. He is a member of the Institute of Medicine of the United States National Academies and the Academy of Medical Sciences (United Kingdom), and has been awarded the 2004 Award for Excellence from the American Public Health Association, the 2005 Donald Mackay Award from the American Society for Tropical Medicine and Hygiene, and the 2007 Heinz Award on the Human Condition. In 2009 he was appointed an honorary Commander of the Most Excellent Order of the British Empire (CBE) for services to global public health.
Professor of Global Health, Milken Institute School of Public Health, George Washington University, USA.
Ron Waldman, MD began his career as a volunteer in the World Health Organization's Smallpox Eradication Program, serving for two years in rural Bangladesh. He joined the Epidemic Intelligence Service of the US Centers for Disease Control and Prevention in 1979 and was assigned to the Michigan State Health Department where he became the principal investigator on case-control studies that established the association between aspirin and Reye Syndrome. He also worked with the Ministry of Health in Somalia and, with colleagues, helped establish the epidemiology of refugee health. After two years as CDC's regional epidemiologist based in Abidjan, Cote d'Ivoire, in 1985 he became Director of the Technical Support Division of CDC's International Health Program Office and worked on both child survival projects and disaster response. From1992 through 1994 he was the Coordinator of the Cholera Control Task Force at the World Health Organization in Geneva.
From 1994-1999 he was assigned by CDC to be Technical Director of the USAID-funded BASICS program, a global child survival effort. During this time he also worked in emergency relief in the Balkans and Central Africa. In 1999 he became Professor of Clinical Population and Family Health and Professor of Clinical Epidemiology at Columbia University's Mailman School of Public Health where he was Founding Director of the Program on Forced Migration and Health. In 2004-5 he was WHO's coordinator during the tsunami emergency in Aceh, Indonesia. In 2007 he became Team Leader for Strategic Preparedness in the Pandemic Influenza and Other Emerging Pandemic Threats Unit of the US Agency for International Development. In 2010 he served as the US Government's health sector coordinator in the Haiti earthquake relief effort and, later that year, as Senior Public Health Advisor to the UN Humanitarian Coordinator during the Pakistan floods disaster response.. He joined the faculty at GW in July 2012.
Associate Researcher, Centre de Sociologie des Organisations (CNRS – SCIENCES PO) and AXA Insurance, France
Dr. Wendling joined AXA in June 2014 as Head of R&D foresight, after working as a foresight senior consultant at Futuribles, in Paris. She is associated researcher at the CSO (CNRS – Sciences po Paris). Her field of research is sociology of risks (health, environment, cyber etc) and catastrophes (Fukushima, etc).
Dr. Wendling is in charge of elaborating deep insights into social, political and technologies trends, conducting horizon scanning on future constraints, opportunities, game changers of the insurance. She connects AXA with academic and research communities in order to develop both internal and external networks of experts focused on the future of insurance (e.g. on topic like blockchain, connected and personalized health, driverless car, artificial intelligence, etc).
She is currently working on the use of blockchain in the insurance sector. The method used to understand the future of blockchain is that of scenario building.
Former Head of Health Emergency Response, Health Service Executive and Ordnance Corps, Irish Defence Forces, Ireland
Mr Daly is currently involved in the early stages of a new digital health startup in Dublin. Before this, he was most recently co-founder and CEO of a company in the area of mobile enterprise apps where he formulated the product vision, built the team, was responsible for product ownership and managed the commercialization. He has a background in the life sciences and formerly founded and ran two biotech startups, one of which was listed on the UK stock exchange. He is interested in such areas as enterprise apps for collaboration, UX and design thinking and gamification.
Specialties: starting and building new technology based companies, agile project management, product management and vision, strategic marketing; market and competitor analysis, lean startup methodolgy; business development, stakeholder management, strong communication and financial management skills and extensive experience in raising equity capital.
Senior scientist, Fraunhofer Institute for Technological Trend Analysis, Germany
Head of Section, Epidemic Intelligence and Response and Deputy Head, Surveillance and Response Support Unit, European Centre for Disease Prevention and Control (ECDC)
Dr. Josep M. Jansà is a medical doctor graduated at the Autonomous University of Barcelona, specialized in Preventive Medicine and Public Health.
Since March 2012, Dr Jansà is working at the European Centre for Disease Prevention and Control (ECDC) Head of Section of Epidemic Intelligence and Response and since 2013 also as Deputy Head of the Surveillance and response Support Unit.
He has been holding different positions at Regional, National and International levels in the areas of epidemiology of infectious diseases, public health surveillance, community health, drug abuse and mental health. During the last 15 years he has focused his professional activity in the areas of response in front of Public Health Emergencies and crisis, International Health and migrant’s health. Since 1991 he has also been involved in different missions of health cooperation, humanitarian and Public health crisis (refugees, armed conflicts, epidemics) and consultancy on health services.
From 2004 to 2014 he has been working as associate Professor at the medical School of the Autonomous University of Barcelona, in charge of the Master on International Health.
Dr Jansà is author of more than 80 scientific publications and has been developing research in the areas of tuberculosis, epidemiology of infectious diseases, migrants’ health and international health.